Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-12

FDA Approved: ACETAZOLAMIDE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for acetazolamide submitted by Ajanta Pharma USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)